Dr Laura Periman, MD discusses biopsychosocial and economic impacts, as well as innovative treatment opportunities for patients with dry eye disease.
K-Cast
Neal Bhatia, MD, discusses atopic dermatitis and the treatment process, as well as how to improve access to therapies for patients with this disease.
Jennifer Brigitte Green, MD, discusses the management of type 2 diabetes for patients not currently controlled on oral antidiabetic medications.
Expert hematologist/oncologist David R. Gandara, MD, highlights the value comprehensive genomic profiling has in guiding therapeutic decisions.
Recommendations for treating HER2-positive metastatic breast cancer with newer HER2-targeted treatment approaches and considerations regarding their adoption into clinical practice.
Paul K. Paik, MD, discusses the spectrum of targeted therapy in non-small cell lung cancer.
Key opinion leader discusses considerations for adult patients with spinal muscular atrophy (SMA) including disease burden, treatment evaluation, and the use of real-world evidence.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
What IRA drug prices will mean for PBMs, health plans and patients
2
Catheter ablation shows benefits for patients with both aFib and sleep apnea
3
Ultra-processed foods linked to early-onset colorectal adenomas in women
4
Biosimilar competition could surpass IRA-negotiated savings by year three
5
